Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Blázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos RM, Resel E, Palazuelos J, Julien B, Salazar M, Börner C, et al.